Abstract:Cortical dysplasia (CD) is a common cause of drug-resistant epilepsy. Increasing studies have implicated innate immunity in CD with epilepsy. However, it is unclear whether innate immune factors induce epileptogenic CD. Here, we injected recombinant human high mobility group box 1 (rHMGB1) into embryonic rat ventricles to determine whether rHMGB1 can induce epileptogenic CD with pathophysiological characteristics similar to those of human CD. Compared with controls and 0.1 μg rHMGB1-treated rats, the cortical organization was severely disrupted in the 0.2 μg rHMGB1-treated rats, and microgyria and heterotopia also emerged; additionally, disoriented and deformed neurons were observed in the cortical lesions and heterotopias. Subcortical heterotopia appeared in the white matter and the gray–white junction of the 0.2 μg rHMGB1-treated rats. Moreover, there was decreased number of neurons in layer V–VI and an increased number of astrocytes in layer I and V of the cortical lesions. And the HMGB1 antagonist dexmedetomidine alleviated the changes induced by rHMGB1. Further, we found that TLR4 and NF-κB were increased after rHMGB1 administration. In addition, the excitatory receptors, N -methyl- D -aspartate receptor 1 (NR1), 2A (NR2A), and 2B (NR2B) immunoreactivity were increased, and immunoreactivity of excitatory amino acid transporter 1 (EAAT1) and 2 (EAAT2) were reduced in 0.2 μg rHMGB1-treated rats compared with controls. While there were no differences in the glutamic acid decarboxylase 65/67 (GAD65/67) immunoreactivity between the two groups. These results indicate that the excitation of cortical lesions was significantly increased. Furthermore, electroencephalogram (EEG) showed a shorter latency of seizure onset and a higher incidence of status epilepticus in the 0.2 μg rHMGB1-treated rats; the frequency and amplitude of EEG were higher in the treated rats than controls. Intriguingly, spontaneous electrographic seizure discharges were detected in the 0.2 μg rHMGB1-treated rats after 5 months of age, and spike-wave discharges of approximately 8 Hz were the most significantly increased synchronous propagated waves throughout the general brain cortex. Taken together, these findings indicate that rHMGB1 exposure during pregnancy could contribute to the development of epileptogenic CD, which mimicked some pathophysiological characteristics of human CD.

Comparative Proteomics of Rat Brain in the BCNU-induced Model of Cortical Dysplasia

Global Protein Differential Expression Profiling of Cerebrospinal Fluid Samples Pooled from Chinese Sporadic CJD and non-CJD Patients

[Changes of Expression of Cation-Chloride Cotransporter Genes in Hippocampus of Cortical Dysplasia: Experiment with Rat].

Functional changes of voltage-dependent sodium channel on hippocampal neurons from rats with cortical developmental disabilities

Gene and Protein Alterations in the Hippocampus of Rats with Temporal Lobe Epilepsy

Proteomic Differences in the Hippocampus and Cortex of Epilepsy Brain Tissue

Novel Therapeutic Target Proteins Expressed in Hippocampi of Rats with Temporal Lobe Epilepsy

Differentially expressed proteins underlying childhood cortical dysplasia with epilepsy identified by iTRAQ proteomic profiling

A Comparative Proteomics Analysis of Rat Mitochondria from the Cerebral Cortex and Hippocampus in Response to Antipsychotic Medications

Comparative proteomics and correlated signaling network of rat hippocampus in the pilocarpine model of temporal lobe epilepsy.

Abnormal Rat Cortical Development Induced by Ventricular Injection of rHMGB1 Mimics the Pathophysiology of Human Cortical Dysplasia

Identification and verification of key molecules in the epileptogenic process of focal cortical dysplasia

Spatial transcriptomics in focal cortical dysplasia type IIb

TMT-based proteomics profile reveals changes of the entorhinal cortex in a kainic acid model of epilepsy in mice

Analysis of Altered Micro RNA Expression Profiles in Focal Cortical Dysplasia IIB.

Changes of autophagy-related genes in the brains of the rats in the developmental stage with epilepsy

Proteomic profiling of the rat hippocampus from the kindling models of electrical epilepsy and treatment with low-frequency deep brain stimulation: the important role of the cytoskeleton

Comparative proteomic analysis of differentially expressed proteins in hippocampus of developmental rats with mesial temporal lobe epilepsy following treatment with valproate

Pathogenesis and Therapeutic Targets of Focal Cortical Dysplasia Based on Bioinformatics Analysis

A Differential Peptidomics Analysis of Hippocampal Tissue in a Rat Model of Premature White Matter Injury

Dynamics of Subcellular Proteomes During Brain Development